OmniComm introduces dedicated Phase I eClinical tool
OmniComm has launched a comprehensive Phase I eClinical tool, which it believes is the first of its kind, to help users make cost and time savings by improving efficiencies.
OmniComm has launched a comprehensive Phase I eClinical tool, which it believes is the first of its kind, to help users make cost and time savings by improving efficiencies.
Xcellerex is using its single use bioreactor system, FlexFactory, to develop a novel manufacturing process for Humacyte’s regenerative medicine candidate.
Payne Security has acquired BP Secure Solutions, adding the UK firm's roster of adhesive security labelling technologies to its drug industry offering.
Indian generic drugmaker Aurobindo Pharma officially launched its CRAMS unit AuroSource last week, also unveiling plans for an R&D facility in Pashamylaram near Hyderabad, India.
Kendle is setting up a facility in a special economic zone (SEZ) in India which will provide clinical support services and be able to rapidly increase staffing in response to spikes in demand.
Inovio Biomedical has developed a hand-held, cordless electroporation device, Cellectra-SP, which it believes is well suited to administering DNA vaccines in mass immunization programmes.